Therapy News and Research

RSS

UGR’s artificial skin shows promising results in major burn treatments

UGR scientists have demonstrated the efficacy and viability of the artificial skin UGRSKIN, an advanced therapy medicinal product (ATMP) they developed in 2012, which has proven to be highly beneficial in the treatment of patients with major burns. Moreover, it does not cause any side effects or significant complications.

23 Feb 2024

New scientific project to explore nature-based therapies for improving mental health

Can mental health benefit from nature-based health therapies? A new scientific project led by the Institute of Environmental Science and Technology of the Universitat Autònoma de Barcelona (ICTA-UAB) will explore how these types of therapies, consisting of frequent exposure to natural green spaces, could be integrated into public health and nature promotion policies to improve the mental health of the population and reduce inequalities in addressing these pathologies.

23 Feb 2024

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Lung cancer is not the most common form of cancer, but it is by far the deadliest.

23 Feb 2024

Genetic signature may help predict disease-free survival in patients with non-small cell lung cancer

A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation.

23 Feb 2024

Study uncovers a biological role of transmembrane protein TMEM208

A recent study conducted in the lab of Dr. Hugo J. Bellen, distinguished service professor at Baylor College of Medicine and principal investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, has discovered a biological role of a specific transmembrane protein called TMEM208.

23 Feb 2024

Research reveals bacteria's dynamic defense duo against phage viruses

Scientists at the University of Southampton have discovered that bacteria can pair up their defense systems to create a formidable force, greater than the sum of its parts, to fight off attack from phage viruses.

23 Feb 2024

Red light therapy shown to significantly reduce blood sugar spikes, study finds

Using red light of 670 nm wavelength impacted the circulating glucose levels in the plasma, using oral glucose tolerance tests.

23 Feb 2024

Natural killer cells lead the charge in cancer treatment innovation

Review synthesizes research on NK cells' role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing preclinical and clinical trials.

22 Feb 2024

New immunotherapy target activin receptor 1C shows promise against cancer

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

22 Feb 2024

Innovative MicroGlucagon solution aims to transform insulin therapy for type 1 diabetics

Researchers in Trondheim are developing a new medicine for diabetics who have to have daily injections of insulin. The key is a hormone that causes the smallest blood vessels to relax on the inside.

22 Feb 2024

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe switch platform and the GoCAR platform.

22 Feb 2024

Understanding and addressing neurodevelopmental challenges in congenital heart disease

More than a decade of new knowledge about neurodevelopmental risk in people with congenital heart disease has changed the thinking about who is most at risk and the factors that impact neurological development, learning, emotions and behaviors, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

22 Feb 2024

Study: Early advanced therapy significantly improves Crohn's disease outcomes

A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically improve outcomes, including by reducing the number of people requiring urgent abdominal surgery for treatment of their disease by ten-fold.

22 Feb 2024

Simple blood test to detect Alzheimer's disease may replace more invasive diagnostic methods

A simple blood test to diagnose Alzheimer's disease soon may replace more invasive and expensive screening methods such as spinal taps and brain scans.

22 Feb 2024

Can dietary patterns impact stomach cancer risk?

Eating patterns and indices related to gastric cancer and explored their association with stomach cancer risk.

22 Feb 2024

Vitamin D3 and phytochemicals team up for immune boost and aging defense, study finds

Review highlights the synergistic effects of vitamin D3 and phytochemicals in promoting immune balance, reducing inflammation, supporting gut health, and combating aging, emphasizing the importance of these nutrients for longevity and vitality.

21 Feb 2024

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue, PhD, associate professor in the Department of Pathology, Sue Chin Lee, PhD, in the Department of Physiology, and David Schwartz, MD, chair of the Department of Radiation Oncology, are part of a scientific leadership group awarded $20 million from the University of Tennessee-Oak Ridge Innovation Institute in partnership with Oak Ridge National Laboratory and the University of Tennessee, Knoxville, to develop new radiopharmaceutical therapies to treat cancer.

21 Feb 2024

COVID-19's neurological effects linked to immune response, not direct viral attack

Study identifies neurocognitive symptoms in COVID-19 patients as a reaction to systemic infection rather than direct brain infection, highlighting changes in the brain's immune response and synaptic organization.

21 Feb 2024

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of the institution.

21 Feb 2024

Study reveals mechanism of drug targeting protein modification in tumor suppressor genes

Researchers have revealed the mechanism of a drug shown to be effective in treating certain types of cancer, which targets a protein modification silencing the expression of multiple tumor suppressor genes.

21 Feb 2024

Therapy News and Research

UGR’s artificial skin shows promising results in major burn treatments

New scientific project to explore nature-based therapies for improving mental health

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Genetic signature may help predict disease-free survival in patients with non-small cell lung cancer

Study uncovers a biological role of transmembrane protein TMEM208

Research reveals bacteria's dynamic defense duo against phage viruses

Red light therapy shown to significantly reduce blood sugar spikes, study finds

Natural killer cells lead the charge in cancer treatment innovation

New immunotherapy target activin receptor 1C shows promise against cancer

Innovative MicroGlucagon solution aims to transform insulin therapy for type 1 diabetics

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

Understanding and addressing neurodevelopmental challenges in congenital heart disease

Study: Early advanced therapy significantly improves Crohn's disease outcomes

Simple blood test to detect Alzheimer's disease may replace more invasive diagnostic methods

Can dietary patterns impact stomach cancer risk?

Vitamin D3 and phytochemicals team up for immune boost and aging defense, study finds

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

COVID-19's neurological effects linked to immune response, not direct viral attack

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

Study reveals mechanism of drug targeting protein modification in tumor suppressor genes

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News